Eyewire News: The Podcast
By Eyewire News
Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Image by Eyewire News
Category: Business News
Open in Apple Podcasts
Open RSS feed
Open Website
Rate for this podcast
Subscribers: 1
Reviews: 0
Episodes: 97
Description
Eyewire News: The Podcast keeps listeners updated with the latest information in the ophthalmic field, featuring breaking news from press releases, medical journals, vision publications, and other news sources.
| Episode | Date |
|---|---|
|
Tecnis PureSee IOL Fully Launched in the US
|
Jun 17, 2026 |
|
Study Examines Semaglutide and Wet AMD Risk
|
Jun 10, 2026 |
|
Oculis Announces Phase 3 Results for DME Eye Drops
|
Jun 03, 2026 |
|
Outlook Wins Appeal for Wet AMD Drug Candidate Lytenava
|
May 27, 2026 |
|
Next-Generation FSYX Goggles Approved for Glaucoma
|
May 20, 2026 |
|
Future of Posterior Therapeutics
|
May 13, 2026 |
|
Bayer Acquires Perfuse in $2.45 Billion Deal
|
May 06, 2026 |
|
How Ophthalmology Strategics are Rewriting the Playbook
|
Apr 29, 2026 |
|
Glaukos Issued J-Code for Recently Launched Epioxa
|
Apr 22, 2026 |
|
Breaking News from the ASCRS Meeting in Washington DC
|
Apr 15, 2026 |
|
More than 3 Million Bottles of Eye Drops Recalled
|
Apr 08, 2026 |
|
Biogen Enters GA Treatment Market After Major Acquisition
|
Apr 01, 2026 |
|
Interview with ASCRS Executive Director Steve Speares
|
Mar 25, 2026 |
|
Alcon and Lensar Call Off Merger
|
Mar 18, 2026 |
|
FDA Agrees to Review Phentolamine for Presbyopia
|
Mar 04, 2026 |
|
Zeiss Launches App to Improve Workflow
|
Feb 25, 2026 |
|
Ocular Releases Phase 3 Data for Wet AMD Candidate Axpaxli
|
Feb 18, 2026 |
|
Study: Metformin May Lower AMD Progression
|
Feb 11, 2026 |
|
First Dual-Agent Eye Drop for Presbyopia Approved
|
Feb 04, 2026 |
|
FDA Approves Label Supplement for iDose TR
|
Jan 28, 2026 |
|
Rayner Launches New Phaco System
|
Jan 21, 2026 |
|
Moorfields Researchers Reveal Promising Treatment for Hypotony
|
Jan 14, 2026 |
|
Staar Terminates Merger with Alcon
|
Jan 07, 2026 |
|
2025 Year in Review - Part 2
|
Dec 31, 2025 |
|
2025 Year in Review - Part 1
|
Dec 24, 2025 |
|
Update on Reproxalap PDUFA Timing
|
Dec 17, 2025 |
|
New Glaucoma Technologies Advance in Clinical Development
|
Dec 10, 2025 |
|
Eylea HD Approved for RVO and Extended Dosing
|
Dec 03, 2025 |
|
Leaders Discuss Emerging Technologies in Glaucoma
|
Nov 26, 2025 |
|
Live Coverage of B+L Investor Day
|
Nov 18, 2025 |
|
Ryjunea Approved in the UK for Myopia
|
Nov 12, 2025 |
|
Ophthalmic Executives Provide Company Updates (Part 2 of 2)
|
Nov 05, 2025 |
|
Ophthalmic Executives Provide Company Updates (Part 1 of 2)
|
Oct 29, 2025 |
|
Breaking News from the AAO Meeting in Orlando
|
Oct 22, 2025 |
|
First Robotic Cataract Surgery Performed
|
Oct 15, 2025 |
|
Lenz Therapeutics' Vizz Commerically Launched
|
Oct 08, 2025 |
|
Visionary Breakthroughs: A Spotlight on Innovations in Eye Care (Part 2 of 2)
|
Oct 01, 2025 |
|
Visionary Breakthroughs: A Spotlight on Innovations in Eye Care (Part 1 of 2)
|
Sep 24, 2025 |
|
Breaking News From the ESCRS Congress in Copenhagen
|
Sep 17, 2025 |
|
Vision Advocacy Leaders Speak Out Against Proposed NEI Cuts
|
Sep 10, 2025 |
|
Update on Investigational Treatments for Retinal Diseases
|
Sep 03, 2025 |
|
CE Certification for New Glaucoma Surgical Implant
|
Aug 27, 2025 |
|
Special Report: TFOS DEWS III Leaders Discuss New DED Guidance
|
Aug 20, 2025 |
|
First Commerical Surgeries Performed with MacTel Therapy
|
Aug 13, 2025 |
|
Alcon Acquires Staar for $1.5 Billion
|
Aug 06, 2025 |
|
Tryptyr Now Available in US
|
Jul 30, 2025 |
|
Harrow Adds Biosimilars to US Portfolio
|
Jul 23, 2025 |
|
AECOS Presentation Summaries
|
Jul 16, 2025 |
|
Alcon Acquires LumiThera
|
Jul 09, 2025 |
|
Glaukos' MIGS Technology Certified in Europe; New Phase 3 Data for Presbyopia Drop
|
Jul 02, 2025 |
|
Special Report: Update on Holland Foundation
|
Jun 25, 2025 |
|
TFOS DEWS III Published
|
Jun 18, 2025 |
|
First Myopia Drug Approved in Europe
|
Jun 11, 2025 |
|
Alcon Gains FDA Approval for Novel DED Drug
|
Jun 04, 2025 |
|
Special Report: Executives Discuss Overcoming Challenges
|
May 28, 2025 |
|
B+L Launches New Scleral Lenses Technology
|
May 21, 2025 |
|
B+L Receives Approval in Europe for LuxLife IOL
|
May 14, 2025 |
|
Ophthalmic Leaders Launch SightLine Meeting
|
May 07, 2025 |
|
Breaking News from the ASCRS Meeting in Los Angeles
|
Apr 30, 2025 |
|
FDA Issues CRL to Regeneron for Eylea HD Extended Dosing
|
Apr 23, 2025 |
|
Orasis Launches Presbyopia Eye Drop Qlosi
|
Apr 16, 2025 |
|
Utilizing AI to Provide DR Screening to Underserved Communities
|
Apr 09, 2025 |
|
Alcon Launches PanOptix Pro in US
|
Apr 02, 2025 |
|
Alcon Announces Plans to Acquire Lensar
|
Mar 26, 2025 |
|
FDA Expands Product Label for Iluvien
|
Mar 19, 2025 |
|
FDA Approves First Treatment for MacTel
|
Mar 12, 2025 |
|
Haag-Streit Launches METIS 900 Microscope
|
Mar 05, 2025 |
|
New Myopia Software on Pentacam AXL
|
Feb 26, 2025 |
|
Alcon Voyager DSLT Fully Launched in US
|
Feb 19, 2025 |
|
AAO Opposes NIH Research Funding Proposal
|
Feb 12, 2025 |
|
FDA Approves Genentech's Susvimo Ocular Implant for DME
|
Feb 05, 2025 |
|
Norlase Launches First Pattern Scanning LIO
|
Jan 29, 2025 |
|
Zeiss MEL 90 Approved by FDA
|
Jan 22, 2025 |
|
Special Report – Increasing Access to Care Through the Cure Blindness Project
|
Jan 15, 2025 |
|
Glaukos Submits NDA for Epi-On CLX Candidate
|
Jan 08, 2025 |
|
2024 Year in Review — Part 2
|
Jan 01, 2025 |
|
2024 Year in Review — Part 1
|
Dec 25, 2024 |
|
B+L Bolsters Glaucoma Offerings with Elios Acquisition
|
Dec 18, 2024 |
|
Phase 3 Results for Novel Sedation Tablet
|
Dec 11, 2024 |
|
Phakic IOL for Presbyopia Approved in Europe
|
Dec 04, 2024 |
|
Special Report: OWL Celebrates 20th Anniversary
|
Nov 27, 2024 |
|
Lumithera CEO Discusses FDA Authorization for Veleda for Dry AMD
|
Nov 20, 2024 |
|
Ophthalmic Executives Provide Company Updates (Part 2 of 2)
|
Nov 13, 2024 |
|
Ophthalmic Executives Provide Company Updates (Part 1 of 2)
|
Nov 06, 2024 |
|
Posterior Segment Company Updates
|
Oct 30, 2024 |
|
Breaking News From the AAO Meeting in Chicago
|
Oct 23, 2024 |
|
B+L Receives FDA Approval for enVista Envy IOL
|
Oct 16, 2024 |
|
Aldeyra Resubmits NDA for DED Drug Reproxalap
|
Oct 09, 2024 |
|
Water-Free Ciclosporin-Based Eye Drop for DED Approved in Europe
|
Oct 02, 2024 |
|
Two Partnerships Formed to Advance Glaucoma Treatments
|
Sep 25, 2024 |
|
Breaking News From the ESCRS Congress in Barcelona (Part 2 of 2)
|
Sep 18, 2024 |
|
Breaking News From the ESCRS Congress in Barcelona (Part 1 of 2)
|
Sep 11, 2024 |
|
Weekly Headlines: First Therapy for Acanthamoeba Keratitis Approved in Europe
|
Sep 04, 2024 |
|
Weekly Headlines: Rayner Unveils First AI-Designed Spiral IOL
|
Aug 28, 2024 |
|
Weekly Headlines: Gene Therapies for IRDs Receive FDA Rare Pediatric Disease Designations
|
Aug 21, 2024 |
|
Weekly Headlines: Aldeyra Reports New Phase 3 Data for DED Drug Candidate Reproxalap
|
Aug 14, 2024 |
|
Weekly Headlines: Two Phase 3 Trials for Dry and Wet AMD Drug Candidates Begin
|
Aug 07, 2024 |